2014 Biotech Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2014 Biotech Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Biotech Jim	1/15/2014 2:03:38 PM
	Read Replies (2) of 487

Since I first heard of NLNK on this board, I will post this here. Pretty interesting presentation at the JPM Healthcare Conference today. The stock started to ramp after the presentation. One can find a link to the webcast on this page: investors.linkp.com Here is a link to the slides, not sure how long they will be available. jpmorgan.metameetings.com I especially like their IDO program, and they have 2 different molecules that have different mechanisms of inhibition. Note that INCY also has an IDO program, but NLNK claims they have the best program. Here are the milestones for these two molecules:

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next